RemeGen Co., Ltd. (REGMF)
USD 1.5
(0.0%)
USD 1.5
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 915.26 Million CNY | 772.67% |
| 2022 | 104.88 Million CNY | 108.41% |
| 2021 | 50.32 Million CNY | 8.04% |
| 2020 | 46.57 Million CNY | 1138.12% |
| 2019 | 3.76 Million CNY | 11.3% |
| 2018 | 3.38 Million CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 184.56 Million USD | 33.71% |
| 2024 Q3 | 190.97 Million USD | -0.03% |
| 2024 Q1 | 138.8 Million USD | 19.36% |
| 2023 Q3 | 85.98 Million USD | -86.3% |
| 2023 Q1 | - USD | -100.0% |
| 2023 FY | 915.26 Million CNY | 772.67% |
| 2023 Q4 | 118.49 Million USD | 37.8% |
| 2023 Q2 | 627.85 Million CNY | 0.0% |
| 2022 Q3 | 1.00 USD | -100.0% |
| 2022 Q2 | 52.7 Million CNY | 5270499900.0% |
| 2022 Q1 | 1.00 USD | -100.0% |
| 2022 FY | 104.88 Million CNY | 108.41% |
| 2022 Q4 | 104.88 Million CNY | 10488050300.0% |
| 2021 Q1 | - USD | -100.0% |
| 2021 FY | 50.32 Million CNY | 8.04% |
| 2021 Q4 | 50.32 Million CNY | 0.0% |
| 2021 Q3 | - USD | -100.0% |
| 2021 Q2 | 68.91 Million CNY | 0.0% |
| 2020 FY | 46.57 Million CNY | 1138.12% |
| 2020 Q4 | 46.57 Million CNY | 0.0% |
| 2020 Q2 | 51.28 Million CNY | 0.0% |
| 2019 FY | 3.76 Million CNY | 11.3% |
| 2019 Q4 | 3.76 Million CNY | 0.0% |
| 2018 FY | 3.38 Million CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | - USD | -Infinity% |
| Nanobac Pharmaceuticals, Incorporated | - USD | -Infinity% |
| SQZ Biotechnologies Company | 20.9 Million USD | -4277.364% |
| Evofem Biosciences, Inc. | 8000.00 USD | -11440687.5% |
| Santhera Pharmaceuticals Holding AG | 1.75 Million USD | -52037.508% |
| Mesoblast Limited | 100.29 Million USD | -812.572% |
| Propanc Biopharma, Inc. | 58.64 Thousand USD | -1560663.617% |
| Genus plc | 228.2 Million USD | -301.079% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | - USD | -Infinity% |
| Marizyme, Inc. | 667.12 Thousand USD | -137094.306% |
| ContraFect Corporation | 2.21 Million USD | -41314.615% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.4 Million USD | -65139.206% |
| Intellipharmaceutics International Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 5.42 Million USD | -16766.606% |
| MultiCell Technologies, Inc. | 36.43 USD | -2512388041.642% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 55.61 Million USD | -1545.801% |
| EV Biologics, Inc. | - USD | -Infinity% |
| Q BioMed Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 2.22 Million USD | -41016.936% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -74410.913% |
| Biomind Labs Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 166.1 Million USD | -451.015% |
| Oncotelic Therapeutics, Inc. | 1.89 Million USD | -48110.61% |
| Skye Bioscience, Inc. | 171.23 Thousand USD | -534422.572% |
| Therapeutic Solutions International, Inc. | 5512.00 USD | -16604816.546% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | - USD | -Infinity% |
| IMV Inc. | 27.39 Million USD | -3240.55% |
| Acro Biomedical Co., Ltd. | - USD | -Infinity% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| GB Sciences, Inc. | 322 Thousand USD | -284143.168% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 11.23 Billion USD | 91.856% |
| Halberd Corporation | 150 Thousand USD | -610075.333% |
| Enzolytics Inc. | - USD | -Infinity% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 300 Thousand USD | -304987.667% |
| Nuo Therapeutics, Inc. | 164.2 Thousand USD | -557290.457% |
| argenx SE | 15.35 Million USD | -5861.072% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 20.31 Million USD | -4406.021% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 4456.00 USD | -20539913.465% |
| Genscript Biotech Corporation | 287.12 Million USD | -218.764% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 126.3 Thousand USD | -724562.317% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -399070.923% |
| American Oriental Bioengineering, Inc. | 554.59 Thousand USD | -164934.169% |
| Provectus Biopharmaceuticals, Inc. | 25.29 Thousand USD | -3617683.312% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 8.26 Million USD | -10975.303% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| BioStem Technologies, Inc. | 265.63 Thousand USD | -344456.628% |
| ONE Bio Corp. | 592.19 Thousand USD | -154453.545% |
| Reve Technologies, Inc. | 1064.00 USD | -86020858.647% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -611649.569% |
| Regen BioPharma, Inc. | 149.61 Thousand USD | -611649.569% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | - USD | -Infinity% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | 229.69 Thousand USD | -398375.778% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | 141 Thousand USD | -649022.695% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 80 Thousand USD | -1143978.75% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -11604.19% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 369.04 Thousand USD | -247905.82% |
| International Stem Cell Corporation | 445 Thousand USD | -205577.079% |
| Bioxytran, Inc. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.15 Million USD | -11130.221% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | 457 Thousand USD | -200176.368% |
| Neutra Corp. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 1.16 Million USD | -78734.022% |
| PureTech Health plc | 18.25 Million USD | -4915.14% |
| Coeptis Therapeutics, Inc. | 150 Thousand USD | -610075.333% |
| IXICO plc | 275 Thousand USD | -332722.909% |
| IntelGenx Technologies Corp. | 11.83 Million USD | -7630.915% |
| Gelesis Holdings, Inc. | 26.3 Million USD | -3378.897% |
| CSL Limited | 11.23 Billion USD | 91.856% |
| Cellectis S.A. | 36.21 Million USD | -2427.573% |